Literature DB >> 10029594

Clonality of isolated eosinophils in the hypereosinophilic syndrome.

H W Chang1, K H Leong, D R Koh, S H Lee.   

Abstract

The idiopathic hypereosinophilic syndrome (IHES) is a rare disorder characterized by unexplained, persistent eosinophilia associated with multiple organ dysfunction due to eosinophilic tissue infiltration. In the absence of karyotypic abnormalities, there is no specific test to detect clonal eosinophilia in IHES. Analysis of X-chromosome inactivation patterns can be used to determine whether proliferative disorders are clonal in origin. Methylation of HpaII and Hha I sites near the polymorphic trinucleotide repeat of the human androgen receptor gene (HUMARA) has been shown to correlate with X-inactivation. In this study, we have used the polymerase chain reaction (PCR) with nested primers to analyze X-inactivation patterns of the HUMARA loci in purified eosinophils from female patients with eosinophilia. Peripheral blood eosinophils were isolated by their autofluoresence using flow cytometric sorting. Eosinophils purified from a female patient presenting with IHES were found to show a clonal pattern of X-inactivation. Eosinophil-depleted leukocytes from this patient were polyclonal by HUMARA analysis, thus excluding skewedness of random X-inactivation. After corticosteroid suppression of her blood eosinophilia, a clonal population of eosinophils could no longer be detected in purified eosinophils. In contrast, eosinophils purified from a patient with Churg-Strauss syndrome and from six patients with reactive eosinophilias attributed to allergy, parasitic infection, or drug reaction showed a polyclonal pattern of X-inactivation by HUMARA analysis. The finding of clonal eosinophilia in a patient presenting with IHES indicates that such patients may have, in reality, a low-grade clonal disorder that can be distinguished from reactive eosinophilias by HUMARA analysis. Further, the method described can be used to monitor disease progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029594

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Eosinophilic myeloproliferative disorders.

Authors:  Amy D Klion
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 2.  Cardiac manifestation of the hypereosinophilic syndrome: new insights.

Authors:  T Kleinfeldt; C A Nienaber; S Kische; I Akin; R G Turan; T Körber; H Schneider; H Ince
Journal:  Clin Res Cardiol       Date:  2010-03-24       Impact factor: 5.460

3.  A young man with persistent eosinophilia.

Authors:  E Messa; D Cilloni; G Saglio
Journal:  Intern Emerg Med       Date:  2007-06       Impact factor: 3.397

Review 4.  Primary eosinophilic disorders: a concise review.

Authors:  Animesh Pardanani; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2008-01       Impact factor: 3.952

Review 5.  Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.

Authors:  Ayalew Tefferi; Jason Gotlib; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2010-01-06       Impact factor: 7.616

6.  A novel, essential control for clonality analysis with human androgen receptor gene polymerase chain reaction.

Authors:  Jeroen P van Dijk; Leonie H Heuver; Bert A van der Reijden; Reinier A Raymakers; Theo de Witte; Joop H Jansen
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

Review 7.  Eosinophilic disorders in various diseases.

Authors:  Jocelyn Celestin; Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.919

Review 8.  Hypereosinophilic syndromes.

Authors:  Florence E Roufosse; Michel Goldman; Elie Cogan
Journal:  Orphanet J Rare Dis       Date:  2007-09-11       Impact factor: 4.123

9.  Current concepts on the pathogenesis of the hypereosinophilic syndrome/chronic eosinophilic leukemia.

Authors:  Yoshiyuki Yamada; Marc E Rothenberg; Jose A Cancelas
Journal:  Transl Oncogenomics       Date:  2006-12-05

10.  Severe Multi-Organ Failure and Hypereosinophilia: When to Call It "Idiopathic"?

Authors:  Massimo Radin; Luca Bertero; Dario Roccatello; Savino Sciascia
Journal:  J Investig Med High Impact Case Rep       Date:  2018-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.